查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710120

2025年心臟标记检测全球市场报告

Cardiac Marker Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年心臟标记检测的市场规模将快速成长。到 2029 年，这一数字将成长至 105.6 亿美元，年复合成长率（CAGR）为 10.1%。预测期内的成长归因于心血管疾病发病率的上升、策略联盟和伙伴关係数量的增加、研发倡议的增加、优惠的报销政策以及对照护现场（POC）测试的需求的不断增长。预测期内的关键趋势包括先进诊断技术、自动分析仪、先进心臟标记检测方法、数位健康技术和整合技术的出现。

心血管疾病的日益普及预计将在未来几年推动心臟标记检测市场的成长。心血管疾病 (CVD) 会影响心臟和血管，包括冠状动脉疾病、心臟衰竭和中风等疾病。不健康饮食、缺乏运动、吸烟、过量饮酒和空气污染等因素导致心血管疾病病例增加。心臟标记检测透过检测心肌损伤时释放的特定生物标记物，在诊断心血管疾病、评估其严重程度和监测其治疗进展中发挥重要作用。例如，美国心臟协会在2024年1月报告称，2023年年龄调整后的心血管疾病死亡率增加了4.0%，从每10万人224.4人增加到233.3人。此外，2021 年美国有 20,114 人死于心臟麻痹。因此，心血管疾病发生率的上升推动了对心臟标记检测的需求。

心臟标记检测市场的主要企业正专注于开发先进产品，例如心臟检测，以提供有关心臟健康和功能的准确和有价值的资讯。这些检测是诊断测试，旨在测量血液和其他样本中的生物标记和其他指标，以帮助评估心臟功能、诊断心血管疾病和评估心臟相关疾病的风险。例如，2023年10月，中国医疗设备公司迈瑞推出了肌钙蛋白i（hs-cTnI）和NT-proBNP心臟生物标记。 hs-cTnI检测法以其高灵敏度、精确度和可靠性而着称，在检测极限 (LoD) 和第 99 个百分位参考上限 (URL) 之间实现 93% 的检测率，并且在第 99 个 URL 处保持 5% 或更低的不精确变异係数 (CV)，超出最低要求。这使得它对于检测心肌损伤极为有用。迈瑞的 NT-proBNP检测法是心臟衰竭领先的心臟标记物，具有较高的准确度（CV<=5%），并最大限度地减少了对 55 种常见心臟药物的干扰，确保准确检测和管理心臟衰竭。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界心臟标记研究PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球心臟标记检测市场：成长率分析
  • 全球心臟标记检测市场表现：规模与成长，2019-2024
  • 全球心臟标记检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球心臟标记检测总目标市场（TAM）

第六章市场区隔

  • 全球心臟标记检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和套件
  • 装置
  • 全球心臟标记检测市场（按生物标记类型、表现和预测）2019-2024 年、2024-2029 年、2034 年
  • 肌钙蛋白 I 和 T
  • 肌酸激酶同功酶（CK-MB）
  • 利钠肽
  • 肌红蛋白
  • 高敏C反应蛋白
  • 其他心臟生物标记
  • 全球心臟标记检测市场：应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室测试设施
  • 就地检验实验室
  • 学术机构
  • 全球心臟标记检测市场按试剂和套件类型、性能和预测进行细分，2019-2024 年、2024-2029 年、2034 年
  • 肌钙蛋白检测套组
  • B型利钠肽（BNP）检测套组
  • 肌酸激酶MB（CK-MB）检测套组
  • 肌红蛋白检测套组
  • 其他心臟生物标记试剂
  • 全球心臟标记检测市场，按仪器类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 就地检验设备
  • 自动化分析设备
  • 免疫检测系统
  • 可携式诊断设备

第七章 区域和国家分析

  • 全球心臟标记检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球心臟标记检测市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 心臟标记检测市场：竞争格局
  • 心臟标记检测市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Tosoh Corporation
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • Randox Laboratories Ltd.
  • Getein Biotech Inc.
  • Fujirebio Inc.
  • Mayo Clinic Laboratories
  • Kainos Medicine Inc.
  • Alere Inc.
  • Nano-Ditech Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年心臟标记检测市场：提供新机会的国家
  • 2029年心臟标记检测市场：细分市场带来新机会
  • 2029年心臟标记检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31699

Cardiac marker testing involves a series of diagnostic tests designed to measure specific substances in the blood that signal damage or stress to the heart. These markers, often proteins or enzymes, are released into the bloodstream when the heart muscle is injured. Cardiac marker tests are vital for diagnosing and assessing conditions such as myocardial infarction (heart attack), heart failure, and other heart-related diseases.

The primary products used in cardiac marker testing include reagents, kits, and instruments. Reagents and kits are crucial components in these tests, containing the necessary chemicals and materials for conducting diagnostics. They provide various biomarkers, such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and others, and are utilized in laboratory testing facilities, point-of-care testing facilities, and academic institutions.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $6.52 $ billion in 2024 to $7.19 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in geriatric population, rise in educational campaigns, increasing awareness, rising healthcare infrastructure, and rising patient population.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $10.56 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising incidences of cardiovascular diseases, increasing strategic collaborations and partnerships, increasing research and development initiatives, favorable reimbursement policies and rising demand for point-of-care (POC) testing. Major trends in the forecast period include advanced diagnostic technologies, automated analyzers, advanced cardiac marker testing assays, digital health technologies, and emergence of integrative technologies.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac marker testing market in the coming years. Cardiovascular diseases (CVDs), encompassing conditions such as coronary artery disease, heart failure, and stroke, affect the heart and blood vessels. Factors such as unhealthy diets, lack of physical activity, tobacco use, excessive alcohol consumption, and air pollution contribute to the rise in CVD cases. Cardiac marker testing plays a crucial role in diagnosing cardiovascular diseases, assessing their severity, and monitoring treatment progress by detecting specific biomarkers released during myocardial injury. For instance, the American Heart Association reported in January 2024 that the age-adjusted death rate from cardiovascular disease increased by 4.0%, from 224.4 per 100,000 in 2023 to 233.3 per 100,000. Additionally, sudden cardiac arrest accounted for 20,114 deaths in the U.S. in 2021. As a result, the growing incidence of cardiovascular diseases is fueling the demand for cardiac marker testing.

Leading companies in the cardiac marker testing market are focusing on the development of advanced products, such as cardiac assays, to provide accurate and valuable information regarding heart health and function. These assays are diagnostic tests designed to measure biomarkers or other indicators in blood or other samples, helping to assess heart function, diagnose cardiovascular diseases, and evaluate the risk of heart-related conditions. For example, in October 2023, Mindray, a medical device company based in China, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay is notable for its high sensitivity, precision, and reliability, surpassing the minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL), and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL. This makes it highly effective in detecting myocardial injury. Mindray's NT-proBNP assay is a key cardiac marker for heart failure, offering high precision with a CV of <=5% and minimizing interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.

In August 2024, VION Biosciences, a US-based life sciences platform, acquired Ansh Labs for an undisclosed amount. This acquisition is intended to bolster VION Biosciences' presence in the diagnostic sector, integrate advanced technologies, and expand its product offerings in immunoassay development. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Instruments
  • 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Cardiac Biomarkers
  • 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
  • Subsegments:
  • 1) By Reagents and Kits: Troponin Test Kits; B-type Natriuretic Peptide (BNP) Test Kits; Creatine Kinase-MB (CK-MB) Test Kits; Myoglobin Test Kits; Other Cardiac Biomarker Reagents
  • 2) By Instruments: Point-of-Care Testing Devices; Automated Analyzers; Immunoassay Systems; Portable Diagnostic Devices
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Marker Testing Market Characteristics

3. Cardiac Marker Testing Market Trends And Strategies

4. Cardiac Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Marker Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Marker Testing Market Growth Rate Analysis
  • 5.4. Global Cardiac Marker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Marker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Marker Testing Total Addressable Market (TAM)

6. Cardiac Marker Testing Market Segmentation

  • 6.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Instruments
  • 6.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin I And T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High-Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers
  • 6.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions
  • 6.4. Global Cardiac Marker Testing Market, Sub-Segmentation Of Reagents and Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin Test Kits
  • B-type Natriuretic Peptide (BNP) Test Kits
  • Creatine Kinase-MB (CK-MB) Test Kits
  • Myoglobin Test Kits
  • Other Cardiac Biomarker Reagents
  • 6.5. Global Cardiac Marker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Point-of-Care Testing Devices
  • Automated Analyzers
  • Immunoassay Systems
  • Portable Diagnostic Devices

7. Cardiac Marker Testing Market Regional And Country Analysis

  • 7.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Marker Testing Market

  • 8.1. Asia-Pacific Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Marker Testing Market

  • 9.1. China Cardiac Marker Testing Market Overview
  • 9.2. China Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Marker Testing Market

  • 10.1. India Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Marker Testing Market

  • 11.1. Japan Cardiac Marker Testing Market Overview
  • 11.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Marker Testing Market

  • 12.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Marker Testing Market

  • 13.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Marker Testing Market

  • 14.1. South Korea Cardiac Marker Testing Market Overview
  • 14.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Marker Testing Market

  • 15.1. Western Europe Cardiac Marker Testing Market Overview
  • 15.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Marker Testing Market

  • 16.1. UK Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Marker Testing Market

  • 17.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Marker Testing Market

  • 18.1. France Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Marker Testing Market

  • 19.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Marker Testing Market

  • 20.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Marker Testing Market

  • 21.1. Eastern Europe Cardiac Marker Testing Market Overview
  • 21.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Marker Testing Market

  • 22.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Marker Testing Market

  • 23.1. North America Cardiac Marker Testing Market Overview
  • 23.2. North America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Marker Testing Market

  • 24.1. USA Cardiac Marker Testing Market Overview
  • 24.2. USA Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Marker Testing Market

  • 25.1. Canada Cardiac Marker Testing Market Overview
  • 25.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Marker Testing Market

  • 26.1. South America Cardiac Marker Testing Market Overview
  • 26.2. South America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Marker Testing Market

  • 27.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Marker Testing Market

  • 28.1. Middle East Cardiac Marker Testing Market Overview
  • 28.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Marker Testing Market

  • 29.1. Africa Cardiac Marker Testing Market Overview
  • 29.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Marker Testing Market Competitive Landscape
  • 30.2. Cardiac Marker Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Marker Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Inc.
  • 31.4. Tosoh Corporation
  • 31.5. bioMerieux SA
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Guangzhou Wondfo Biotech Co. Ltd.
  • 31.9. Randox Laboratories Ltd.
  • 31.10. Getein Biotech Inc.
  • 31.11. Fujirebio Inc.
  • 31.12. Mayo Clinic Laboratories
  • 31.13. Kainos Medicine Inc.
  • 31.14. Alere Inc.
  • 31.15. Nano-Ditech Corporation

32. Global Cardiac Marker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

34. Recent Developments In The Cardiac Marker Testing Market

35. Cardiac Marker Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Marker Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Marker Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Marker Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer